Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
 
HOUSE OF COMMONS   CHAMBRE DES COMMUNES
2nd Session, 39th Parliament   2e Session, 39e législature

 
NOTICE OF MEETING   AVIS DE CONVOCATION
 
Standing Committee on Health   Comité permanent de la santé
 
Meeting No. 10 Séance no 10
Tuesday, February 5, 2008 Le mardi 5 février 2008
11:00 a.m. to 1:00 p.m. 11 heures à 13 heures
Room 237-C, Centre Block   Pièce 237-C, édifice du Centre
(613-943-1496)   (613-943-1496)
 

 
 
Orders of the Day   Ordre du jour
 
 
Post-Market Surveillance of Pharmaceutical Products Surveillance post-commercialisation des produits pharmaceutiques
 
Panel on Industry Groupe d'experts sur l'industrie
 
Witnesses Témoins
 
NDMAC ACIMVL
 
David Skinner, President David Skinner, président
 
Robert White, Director
Scientific and Regulatory Affairs
 Robert White, directeur
Affaires scientifiques et réglementaires
 
Canada's Research-Based Pharmaceutical Companies (Rx & D) Les compagnies de recherche pharmaceutique du Canada (Rx & D)
 
Pier-Giorgio Fontana, Consultant
Regulatory Affairs
 Pier-Giorgio Fontana, conseiller
Affaires réglementaires
 
BIOTECanada BIOTECanada
 
Philip Schwab, Vice-President of Industry Relations Philip Schwab, vice-président des relations avec l'industrie
 
Canadian Generic Pharmaceutical Association Association canadienne du médicament générique
 
Colin D'Cunha, Director, Pharmacovigilance
Apotex Inc.
 Colin D'Cunha, directeur, pharmacovigilance
Apotex inc.
 
Jacqueline Conant, Principal Consultant, Pharmacovigilance
Apotex Inc.
 Jacqueline Conant, expert-conseil principale, pharmacovigilance
Apotex inc.
 
 
La greffière du Comité
Carmen DePape ((613) 995-4108)
Clerk of the Committee
 
2008/01/31 2:52 p.m.   2008/01/31 14 h 52